Page last updated: 2024-11-06

romifidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Romifidine is an alpha-2 adrenergic agonist used in veterinary medicine for its sedative and analgesic properties. It is synthesized through a series of chemical reactions starting with the precursor 2-amino-3-(4-chlorophenyl)-1,1-dimethylpropan-1-ol. Romifidine's effects are mediated through the activation of alpha-2 adrenergic receptors, resulting in a decrease in sympathetic nervous system activity. This leads to a reduction in heart rate, blood pressure, and muscle tension. The drug is primarily used for sedation and analgesia in horses, cattle, and other animals. Romifidine is studied for its ability to provide effective sedation and analgesia with minimal side effects. Its use is particularly relevant for procedures requiring short-term sedation and analgesia, such as surgery and diagnostic imaging. Research on romifidine aims to further understand its mechanisms of action, optimize its dosage, and explore its potential applications in other animal species.'

romifidine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71969
CHEMBL ID2105424
SCHEMBL ID246009
MeSH IDM0205197

Synonyms (40)

Synonym
c9h9brfn3
romifidinum [latin]
2-(2-bromo-6-fluoroanilino)-2-imidazoline
romifidine
sedivet
romifidina [spanish]
n-(2-bromo-6-fluorophenyl)-4,5-dihydro-(1h)-imidazol-2-amine
romifidine (inn)
D08487
65896-16-4
sedivet (tn)
n-(2-bromo-6-fluorophenyl)-4,5-dihydro-1h-imidazol-2-amine
CHEMBL2105424
unii-876351l05k
romifidinum
romifidina
876351l05k ,
romifidine [inn:ban]
romifidine [mart.]
romifidine [mi]
romifidine [inn]
SCHEMBL246009
MLS006010405
smr004701406
R0120
2-(2-bromo-6-fluorophenylamino)-2-imidazoline
DTXSID40216103 ,
AKOS026348206
SR-01000945279-1
sr-01000945279
DB11543
mfcd00868606
Q747850
NCGC00532499-01
HY-119456
CS-0068423
EN300-177066
dtxcid00138594
romifidinum (latin)
romifidine (mart.)

Research Excerpts

Overview

Romifidine is an alpha-2 adrenergic agonist used for sedation and analgesia in horses.

ExcerptReferenceRelevance
"Romifidine is an alpha-2 adrenergic agonist used for sedation and analgesia in horses. "( Pharmacokinetics and selected pharmacodynamics of romifidine following low-dose intravenous administration in combination with exercise to quarter horses.
Knych, HK; McKemie, DS; Stanley, SD; Steinmetz, SJ, 2017
)
2.15

Actions

ExcerptReferenceRelevance
"For romifidine, the increase of mean thresholds compared to placebo was 4.0 +/- 1.3 times placebo levels with the electrical current test compared to 1.3 +/- 0.3 times for the mechanical pressure test (p = 0.037)."( A comparison of the antinociceptive effects of xylazine, detomidine and romifidine on experimental pain in horses.
Doherr, MG; Lanz, F; Moens, Y; Schatzmann, U, 2003
)
1.03

Pharmacokinetics

A two compartmental model best described the romifidine pharmacokinetic profile.

ExcerptReferenceRelevance
" The elimination half-life (t(1/2 z)) obtained was 62."( Pharmacokinetics of intramuscular ketamine in young ostriches premedicated with romifidine.
Ballesteros, C; De Lucas, JJ; González, F; Marín, M; Rodríguez, C; San Andrés, MI, 2007
)
0.57
") administration and describe the relationship between PK parameters and simultaneously recorded pharmacodynamic (PD) parameters."( Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse.
Boston, RC; Driessen, B; Rudy, JA; Soma, LR; Uboh, CE; Wojtasiak-Wypart, M, 2012
)
0.63
"To investigate the effects of MK-467 on sedation quality, and cardiopulmonary and pharmacokinetic variables in horses sedated intravenously (IV) with romifidine."( Clinical effects and pharmacokinetic variables of romifidine and the peripheral α
de Vries, A; Ekiri, A; Pakkanen, SA; Raekallio, MR; Scheinin, M; Taylor, PM; Vainio, OM, 2016
)
0.89
" Mean ± SD systemic clearance, steady-state volume of distribution and terminal elimination half-life were 34."( Pharmacokinetics and selected pharmacodynamics of romifidine following low-dose intravenous administration in combination with exercise to quarter horses.
Knych, HK; McKemie, DS; Stanley, SD; Steinmetz, SJ, 2017
)
0.71
"A two compartmental model best described the romifidine pharmacokinetic profile."( Pharmacokinetic-pharmacodynamic modelling of the antinociceptive effect of a romifidine infusion in standing horses.
Diez Bernal, S; Levionnois, O; Spadavecchia, C; Studer, N; Thormann, W, 2020
)
1.05

Compound-Compound Interactions

ExcerptReferenceRelevance
" Use of morphine and butorphanol in combination with alpha2 agonists should be further investigated to assess their analgesic effects."( Comparison of morphine and butorphanol as pre-anaesthetic agents in combination with romifidine for field castration in ponies.
Brearley, JC; Corletto, F; Raisis, AA, 2005
)
0.55

Dosage Studied

ExcerptRelevanceReference
" In the main trial (romifidine combinations) mean time (minutes) to standing increased with increasing dosage (R40TZ1 13; R80TZ2 32)."( Romifidine and low doses of tiletamine-zolazepam in dogs.
Domínguez, JM; Fernández, A; Gómez-Villamandos, RJ; Granados, MM; López, I; Martínez, C; Morgaz, J; Muñoz, P; Navarrete, R, 2013
)
2.16
" When a combination failed to meet those criteria in 2 piglets, the next dosage of the DRT was tested."( Evaluation of different dose rate combinations of ketamine, romifidine and azaperone for castration of 3-4 and 5-6 weeks old piglets.
Bettschart-Wolfensberger, R; Cap, VH; Echtermann, T; Hug, PJ; Janett, F; Nussbaumer, I; Von Ah, S, 2017
)
0.7
" Subsequently a dosage algorithm for the main trial was developed."( [Evaluation of a field-suitable injection anesthesia protocol for the castration of 8 to 14 days old piglets].
Bettschart-Wolfensberger, R; Nussbaumer, I; Rigamonti, S; Schwarz, A, 2018
)
0.48
" Les résultats ont servi de base pour l’algorithme de dosage de l’essai principal."( [Evaluation of a field-suitable injection anesthesia protocol for the castration of 8 to 14 days old piglets].
Bettschart-Wolfensberger, R; Nussbaumer, I; Rigamonti, S; Schwarz, A, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (108)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's21 (19.44)18.2507
2000's42 (38.89)29.6817
2010's38 (35.19)24.3611
2020's7 (6.48)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.59 (24.57)
Research Supply Index5.11 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index64.56 (26.88)
Search Engine Supply Index2.16 (0.95)

This Compound (40.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials56 (51.38%)5.53%
Reviews1 (0.92%)6.00%
Case Studies1 (0.92%)4.05%
Observational0 (0.00%)0.25%
Other51 (46.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]